Literature DB >> 29611494

Reducing Clostridium difficile Colitis Rates Via Cost-Saving Diagnostic Stewardship.

Christina Yen1, Paul Holtom1, Susan M Butler-Wu1, Noah Wald-Dickler1, Ira Shulman1, Brad Spellberg1.   

Abstract

We conducted a quality improvement project at a large public tertiary-care academic hospital to reduce reported hospital-acquired Clostridium difficile infection (CDI) rates. We introduced diagnostic stewardship and provider education, resulting in a 2-fold reduction in C. difficile nucleic acid amplification test (NAAT) orders and markedly lower hospital CDI rate.Infect Control Hosp Epidemiol 2018;39:734-736.

Entities:  

Mesh：

Year:  2018        PMID： 29611494     DOI： 10.1017/ice.2018.51

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


  10 in total

1.  It Is Not about the Assay: Preanalytical Screening Is the Key to Reducing Clostridioides difficile Infection.

Authors:  Siu-Kei Chow; Azita Naderpour; Julianna Van Enk
Journal:  J Clin Microbiol       Date:  2019-01-30       Impact factor: 5.948

2.  Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes.

Authors:  Alice Y Guh; Yi Mu; Lisa G Winston; Helen Johnston; Danyel Olson; Monica M Farley; Lucy E Wilson; Stacy M Holzbauer; Erin C Phipps; Ghinwa K Dumyati; Zintars G Beldavs; Marion A Kainer; Maria Karlsson; Dale N Gerding; L Clifford McDonald
Journal:  N Engl J Med       Date:  2020-04-02       Impact factor: 91.245

3.  The Role of Diagnostic Stewardship in Clostridioides difficile Testing: Challenges and Opportunities.

Authors:  Frances J Boly; Kimberly A Reske; Jennie H Kwon
Journal:  Curr Infect Dis Rep       Date:  2020-02-17       Impact factor: 3.725

4.  Impact of a division-wide bundle on hospital-acquired Clostridioides difficile cases, antibiotic days of therapy, testing appropriateness, and associated financial costs.

Authors:  Elizabeth Wenqian Wang; Ashlee Weekley; Jennifer McCarty; Hoonmo Koo; Bradley Lembcke; Mayar Al Mohajer
Journal:  Avicenna J Med       Date:  2021-01-05

5.  Incidence and Risk Factors for Inappropriate Use of Non-Culture-Based Fungal Assays: Implication for Diagnostic Stewardship.

Authors:  Hiroshi Ito; Koh Okamoto; Shinya Yamamoto; Marie Yamashita; Yoshiaki Kanno; Daisuke Jubishi; Mahoko Ikeda; Sohei Harada; Shu Okugawa; Kyoji Moriya
Journal:  Open Forum Infect Dis       Date:  2021-12-06       Impact factor: 3.835

6.  Assessment of Federal Value-Based Incentive Programs and In-Hospital Clostridioides difficile Infection Rates.

Authors:  Mohammad Alrawashdeh; Chanu Rhee; Heather Hsu; Rui Wang; Kelly Horan; Grace M Lee
Journal:  JAMA Netw Open       Date:  2021-10-01

7.  Rethinking the "Pan-Culture": Clinical Impact of Respiratory Culturing in Patients With Low Pretest Probability of Ventilator-Associated Pneumonia.

Authors:  Owen R Albin; Louis Saravolatz; Joshua Petrie; Oryan Henig; Keith S Kaye
Journal:  Open Forum Infect Dis       Date:  2022-04-14       Impact factor: 4.423

8.  Diagnostic stewardship and the 2017 update of the IDSA-SHEA Clinical Practice Guidelines for Clostridium difficile Infection.

Authors:  Gregory R Madden; Melinda D Poulter; Costi D Sifri
Journal:  Diagnosis (Berl)       Date:  2018-09-25

9.  Impact of Case-Specific Education and Face-to-Face Feedback to Prescribers and Nurses in the Management of Hospitalized Patients With a Positive Clostridium difficile Test.

Authors:  Valeria Fabre; Theodore Markou; Anna Sick-Samuels; Clare Rock; Edina Avdic; Stephanie Shulder; Kathryn Dzintars; Heather Saunders; Jennifer Andonian; Sara E Cosgrove
Journal:  Open Forum Infect Dis       Date:  2018-09-10       Impact factor: 3.835

10.  Improving Appropriate Diagnosis of Clostridioides difficile Infection Through an Enteric Pathogen Order Set With Computerized Clinical Decision Support: An Interrupted Time Series Analysis.

Authors:  Catherine Liu; Kristine Lan; Elizabeth M Krantz; H Nina Kim; Jacqlynn Zier; Chloe Bryson-Cahn; Jeannie D Chan; Rupali Jain; John B Lynch; Steven A Pergam; Paul S Pottinger; Ania Sweet; Estella Whimbey; Andrew Bryan
Journal:  Open Forum Infect Dis       Date:  2020-08-21       Impact factor: 3.835
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.